Comparing two forms of navenibart in healthy adults
This study tests whether two different presentations (forms) of an experimental medicine called navenibart work the same way in your body. Researchers will measure how the drug moves through your system to ensure both forms are safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old
- You are in good overall health with no serious medical conditions
- You weigh between 110 and 220 pounds and have a normal BMI (18–30)
- You have never taken navenibart before
- You are not pregnant, breastfeeding, or planning to become pregnant during the study
- You agree to not use tobacco, nicotine, alcohol, marijuana, or recreational drugs during the trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called SAB01 in healthy adults to see if it is safe and how the body handles it. It is a first-in-human trial, meaning this is the first time the drug is given to people.
This study compares different versions of the investigational drug cenvacibart in healthy volunteers. It helps researchers understand how the drug behaves in the body when given in different forms.
This trial tests a single dose of an experimental drug (BIIB144) in healthy adults to see if it is safe and how the body handles it. You would receive either the drug or a placebo (inactive shot) and be closely monitored.
This study checks if a new injectable medication (RAY1225) behaves the same in the body as the original version. It is for healthy adults and will compare the two forms to make sure they are alike.
This first-in-human study tests the safety of a new medicine called VNT-101. Healthy adults aged 18 to 59 who do not smoke and have no major health problems may be able to join. The goal is to see how the body handles the drug and if it is safe.
This study tests a new medicine (INCA033989) given as a shot or IV in healthy adults to see how the body processes it and if it's safe.
Hear when a new Healthy Adult Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.